Early Prediction of Response to Neoadjuvant Chemotherapy Using Quantitative Parameters on Automated Breast Ultrasound Combined with Contrast-Enhanced Ultrasound in Breast Cancer
This prospective study was aimed at evaluating the role of automated breast ultrasound (ABUS) and contrast-enhanced ultrasound (CEUS) in the early prediction of treatment response to neoadjuvant chemotherapy (NAC) in patients with breast cancer.
Source: Ultrasound in Medicine and Biology - Category: Radiology Authors: Yongwei Xie, Yu Chen, Qiucheng Wang, Bo Li, Haitao Shang, Hui Jing Tags: Original Contribution Source Type: research
More News: Biology | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Radiology | Study | Ultrasound